Now showing items 1-1 of 1

    • Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling 

      Bhatt, Rupal; Wang, Xiaoen; Zhang, Liang; Collins, M. P.; Signoretti, Sabina; Alsop, David; Goldberg, S. N.; Atkins, Michael; Mier, James (American Association for Cancer Research (AACR), 2010-08-10)
      Treatment of metastatic renal cell cancer (RCC) with antiangiogenic agents that block vascular endothelial growth factor (VEGF) receptor 2 signaling produces tumor regression in a substantial fraction of patients; however ...